Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · IEX Real-Time Price · USD
4.190
+0.080 (1.95%)
At close: May 3, 2024, 4:00 PM
4.220
+0.030 (0.72%)
After-hours: May 3, 2024, 4:53 PM EDT
Autolus Therapeutics Employees
Autolus Therapeutics had 463 employees on December 31, 2023. The number of employees increased by 64 or 16.04% compared to the previous year.
Employees
463
Change (1Y)
64
Growth (1Y)
16.04%
Revenue / Employee
$3,667
Profits / Employee
-$450,071
Market Cap
729.48M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 463 | 64 | 16.04% |
Dec 31, 2022 | 399 | 75 | 23.15% |
Dec 31, 2021 | 324 | -52 | -13.83% |
Dec 31, 2020 | 376 | 86 | 29.66% |
Dec 31, 2019 | 290 | 124 | 74.70% |
Sep 30, 2018 | 166 | 40 | 31.75% |
Dec 31, 2017 | 126 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
AUTL News
- 9 days ago - Abstract for longer-term follow-up and additional data analysis of Pivotal Phase 2 FELIX study of obe-cel for adult r/r B-ALL selected for an oral presentation at ASCO - GlobeNewsWire
- 10 days ago - Autolus Therapeutics to Report First Quarter 2024 Financial Results and Host Conference Call on May 14, 2024 - GlobeNewsWire
- 4 weeks ago - Autolus Therapeutics Announces Changes to its Board of Directors - GlobeNewsWire
- 7 weeks ago - Autolus Therapeutics Reports Full Year 2023 Financial Results and Business Updates - GlobeNewsWire
- 7 weeks ago - Autolus Therapeutics receives Medicines and Healthcare products Regulatory Agency (MHRA) certification for Nucleus commercial manufacturing site - GlobeNewsWire
- 2 months ago - Autolus Therapeutics to Report Full Year 2023 Financial Results and Business Updates on March 14, 2024 - GlobeNewsWire
- 3 months ago - Autolus Announces Pricing of Underwritten Offering - GlobeNewsWire
- 3 months ago - BioNTech and Autolus Announce Strategic CAR-T Cell Therapy Collaboration to Advance Pipeline and Expand Late-Stage Programs - GlobeNewsWire